1[1]Kim NW, Piatyszed MA, Prowse KB, et al. Specific association of human telomerase with immortal cells and cancer [J]. Science, 1994,266:2011-2015.
2[2]Savoysky E, Akamatsu K, Tsuchiya M, et al. Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA) [J]. Nucleic Acids Res, 1996, 24:1175-1176.
3[3]Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers [J]. J Natl Cancer Inst, 1995, 87:895-902.
4[4]Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995, 55(150):3258-3262.
5[5]Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996, 88:116-122.
6[6]Kishimoto Y, Murakami Y, Shiraishi, et al. Aberration of the p53 tumor suppressor gene in human non-small cell carcinoma of the lung [J]. Cancer Res, 1992, 52:4799-4804.
7[7]Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer [J]. Cancer Res, 1992, 52:4828-4831.
8[8]Brambilla E, Gazzeri S, Moro D, et al. Immunohistochemical study of p53 in human lung carcinomas [J]. AM J Pathol, 1993, 143:199-210.
9[9]Lamdberg G, Nielsen NH, Nilsson P, et al. Telomerase activity in associated with cell cycle deregulation in human breast cancer[J]. Cancer Res, 1997, 57:549-554.
7Ko LJ, Prives C. p53: puzzle and paradigm[J].Genes Dev. 1996,10(9):1054-72.
8Zhang WW, Fang XF, Mazur W, et al. High efficiency gene transfer and high level expression of wild type p53 in human lung cancer cells mediated by recombinant adenovirus[J]. Cancer Gene Therapy, 1994, 1:5-13.
9Aubert M, Blaho JA. Viral oncoapoptosis of human tumor cells[J]. Gene Ther,2003,10(17):1437-45.
10Merritt JA, Clayman G, Schwisher S, et al. Clinical gene therapy strategies: phase I/II results with adenoviral p53 (INGN 201) gene transfer in advanced head and neck and non-small cell lung cancers[J]. Cancer Gene Therapy, 1997, 4:330-338.
